Modern Adult Obesity Management: New VA/DoD Guidelines
Effective adult obesity management requires recognizing obesity as a chronic, relapsing neurohormonal disease. Recently, the U.S. Department of Veterans Affairs and Department of Defense released updated clinical practice guidelines. These recommendations modernize primary care strategies across diverse patient populations.
Screening and Risk Assessment in Adult Obesity Management
First, clinicians should perform routine obesity screening in all adults. Screening relies on body mass index measurements alongside waist circumference assessments. For the general population, a BMI threshold of 25 kg/m² indicates overweight. However, clinicians should apply a lower threshold of 23 kg/m² for Asian adults. In addition, evaluating clinical context helps refine individual cardiometabolic risk.
Comprehensive Lifestyle Interventions and Pharmacotherapy
Comprehensive lifestyle intervention remains the foundational cornerstone of long-term care. Therefore, healthcare teams must provide nutrition, physical activity, and behavioral support. Interestingly, the updated guidelines eliminate the requirement to complete lifestyle interventions before initiating medications. Consequently, providers can initiate pharmacotherapy concurrently with lifestyle modifications. Furthermore, clinicians should utilize glucagon-like peptide-1 receptor agonists when appropriate. Providers must also avoid discontinuing effective anti-obesity medications to prevent weight regain. Practitioners looking to deepen their expertise in this area can explore the Certification Course In Diabetes And Metabolic Disorder Care.
Procedural and Surgical Interventions
Additionally, modern obesity care incorporates advanced procedural options. Metabolic and bariatric surgery provides substantial benefits for eligible individuals with severe obesity. Similarly, endoscopic bariatric therapies offer minimally invasive alternatives for selected patients. Thus, multidisciplinary teams should personalize interventions to achieve sustained health outcomes.
Frequently Asked Questions
Q1: What BMI thresholds define overweight in different adult populations?
Standard guidelines define overweight as a BMI of 25 kg/m² or higher. However, clinicians recommend a lower threshold of 23 kg/m² for Asian adults due to higher visceral adiposity risks.
Q2: Should anti-obesity medications be stopped after achieving weight loss goals?
No, because obesity is a chronic disease, stopping effective medications often causes rapid weight regain. Therefore, guidelines discourage routine medication discontinuation.
Q3: Is completing lifestyle therapy required before starting medications?
No, the updated guidelines do not require patients to fail or complete lifestyle therapy before starting anti-obesity pharmacotherapy. Primary care physicians aiming to update their overall clinical approach can benefit from enrolling in a Certification Course In General Practice.
References
- Corrado RL et al. Adult Overweight and Obesity Management: Updates From the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. Ann Intern Med. 2026 Aug 25. doi: 10.7326/ANNALS-26-00676. PMID: 42636450.
- U.S. Department of Veterans Affairs, U.S. Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Adult Overweight and Obesity. Washington, DC: VA/DoD; 2025.
- Misra A, Chowbey P, Makkar BM, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163-170.
